Presidential Symposium: Patient-centered healthcare: from challenge to change
Co-chairs: J Helen Cross (United Kingdom) and Francesca Sofia (Italy)

• Fostering Inclusion: Challenges and Promises in Collaborative Epilepsy Care and Research – Laura Lubbers (USA) and Daniel H. Löwenstein (USA)
• A significant success story by a patient/advocate about impactful actions driven by the patient community – Ana Suller Marti (Canada)
• Setting research priorities – involving those who matter – Laura M’Rabet (Netherlands)
• What are the benefits of PPI for people with epilepsy and what are the benefits of PPI for researchers? – Sophie Bennett (United Kingdom) and Emma Dalrymple (United Kingdom)
• Can patient engagement reduce healthcare expenditure, improve effectiveness and ultimately increase value of healthcare and foster growth of the industry sector? – Samuel Wiebe (Canada)

Main Session 1

Session title: Primary brain tumors and epilepsy: advances on pathogenesis, interactions, and therapies
Co-chairs: Aristea Galanopoulou (USA) and Eleonora Aronica (Netherlands)

• Living experience perspective – Landis Wiedner (USA)
• Developmental glioneuronal tumors – molecular underpinnings of tumor- and epilepto-genesis – Silvia Cases-Cunillera (France)
• High grade gliomas - Molecular insights on natural history and epileptogenesis – Jeffrey Noebels (USA)
• Tumor-brain interface in glioblastoma epileptogenesis – Yudan Chi (China)
• Individualizing management of brain tumors and epilepsy – Michael Weller (Switzerland)

Main Session 2

Session title: The Evolving Landscape of Epilepsy Diagnosis and Management
Co-chairs: Melody Asukile (Zambia) and Ley Sander (United Kingdom)

• Introduction - Lived experiences (video) – patient and provider experience relating to climate change, disease outbreaks and conflict – Melody Asukile (Zambia)
• Epilepsy and the Environment – A reflection on the challenges that environmental factors pose on epilepsy management, including the effects of disease outbreaks, conflict, and climate change – Medine Gulcebi (Turkey)
• Precision Medicine: The changing face of epilepsy diagnosis and management through genetics – Rikke Møller (Denmark)
• The role of artificial intelligence in the diagnosis and management of epilepsy – Arjune Sen (United Kingdom)
• Specialised epilepsy care at different settings and resource levels – Patricia Braga (Uruguay)

Main Session 3

Session title: Epilepsy Surgery in Children: Pushing the Limits
Co-chairs: Elaine Wirrell (USA) and Julia Jacobs LeVan (Canada)

• Patient story – focus on journey to get to epilepsy surgery and what benefits they saw with surgery, also which comorbidities persisted/worsened – Emma Nott (United Kingdom)
• Does one size fit all when defining drug resistance? Balancing surgical risk and maximizing neurobehavioral outcomes – Deepak Gill (Australia)
• Should non-curative surgery be the last resort? – Ana Paula Goncalves (Brazil)
• What is the role of less invasive surgical options? – Martin Tisdall (United Kingdom)
• Challenges and lessons of building a pediatric epilepsy surgery program in a resource-limited region – Manjari Tripathy (India)
• What are the benefits of epilepsy surgery beyond just seizure control? – Georgia Ramantani (Switzerland)

Main Session 4

Session title: Translating new frontiers in cognitive and psychological disorders to improved patient outcomes
Co-chairs: Genevieve Rayner (Australia) and Rosa Michaelis (Germany)

• Can you fix both at once please? The cognitive load of mental health problems as a person with epilepsy – Leonie Wollscheid (Germany)
• An expanded paradigm for understanding cognitive disorders in epilepsy – Robyn Busch (USA)
• Next generation cognitive prehabilitation and rehabilitation for all persons with epilepsy – Honor Coleman (Australia) and Shivani Sharma (India)
• Precision methods for understanding psychiatric comorbidities in epilepsy – Genevieve Rayner (Australia)
• Technology-assisted mental health care in epilepsy - friend or foe? – Gus Baker (United Kingdom)

Main Session 5

Session title: The Global Epilepsy Needs Study – Addressing the Unmet Needs of People with Epilepsy
Co-chairs: Graeme Shears (Australia) and Gus Baker (United Kingdom)

• Welcome & GENS session overview – Graeme Shears (Australia)
• The Global Epilepsy Needs Study in Argentina – Maria Marta Bertone (Argentina)
• What are the priority unmet needs of people with epilepsy worldwide? – Gus Baker (United Kingdom) and Claire Nolan (United Kingdom)
• How can IGAP be leveraged to address the everyday unmet needs of people with epilepsy worldwide? – Donna Walsh (Ireland) and Chahnez Triki (Tunisia)
• Multi-stakeholder panel: Perspectives of addressing the unmet everyday needs of people with epilepsy: what can we learn from GENS? – Donna Walsh (Ireland), Francesca Sofia (Italy), J Helen Cross (United Kingdom), Chahnez Triki (Tunisia), Eugenia Roza (Romania), and Maria Marta Bertone (Argentina)
• GENS from my perspective: A call to action – Jessica Veach (USA)
• Conclusion and final thoughts – Gus Baker (United Kingdom)

Main Session 6

Session title: Understanding and using neuromodulation for refractory epilepsy
Co-chairs: Arthur Cukiert (Brazil) and Antonio Valentin (United Kingdom)

• Mechanisms of action of neuromodulation – Antonio Valentin (United Kingdom)
• Biomarkers in neuromodulation – Lawrence Hirsch (USA)
• Neuromodulation for treatment of focal epilepsy – Arthur Cukiert (Brazil)
• Neuromodulation for treatment of generalized epilepsy – Mark Richardson (USA)
• Moving forward: Do we need thalamic recordings to guide neuromodulation? – Linda Dalic (Australia)

Challenge Session 1

Session title: Clinical Trials for Rare and Severe Epilepsies: Progress and Challenges
Co-chairs: Elaine Wirrell (USA) and Sindhu Viswanathan (Malaysia)

• Alternative trial designs to ensure relevance to real world patients – Stéphane Auvin (France)
• The challenges of including non-seizure outcomes as endpoints – Joseph Sullivan (USA)
• Are such trials feasible outside of high-resource regions? – Kette Valente (Brazil)
• Challenges and lessons learned in designing first in human trials of genetic therapies – Sal Rico (USA)

Challenge Session 2

Session title: Managing the complexities of mood and behavior in epilepsy: Nursing perspectives
Co-chairs: Patricia Shafer (USA) and Brialie Forster (Australia)

• Lived experiences: Coping with epilepsy and emotional/behavioral challenges – Laura M'Rabet (Netherlands)
• Role of stigma and biology on dual diagnosis of epilepsy and mood/behavior challenges – Gus Baker (United Kingdom)
• Challenges and best practices for care of people with epilepsy and co-morbidities in outpatient and community settings – Symon Kariuki (Kenya)
• Managing epilepsy and co-morbidities on the EMU – Patricia Shafer (USA)
• Management of Postictal and Behavioral Issues in the EMU – Carolyn McDonald (USA)

Challenge Session 3

Session title: Recent advances and future directions in NORSE/FIRES research.
Co-chairs: Aurelie Hanin (France) and Sara Parreira (Portugal)

• Diagnosis, clinical features, and outcomes in NORSE/FIRES – Francesca Bisulli (Italy)
• Pathophysiological mechanisms underlying NORSE and its consequences: cytokine and single-cell transcriptomic analyses – Aurelie Hanin (France)
• Treatment strategies for NORSE/FIRES: available medications and future possible clinical trials – Lawrence Hirsch (USA)
• Supporting families affected by NORSE – Nora Wong (USA)

Challenge Session 4

Session title: Self-Limited Focal Epilepsies in Infants and Children: Diagnostic and management challenges
Co-chairs: Elaine Wirrell (USA) and Lynette Sadleir (New Zealand)

• Making the diagnosis of Neonatal and Infantile SeLFEs – Jithangi Wanagasinghe (Sri Lanka)
• Management of neonatal and infantile SeLFEs - what is the evidence? – Kelly Knupp (USA)
• Making the diagnosis of childhood SeLFEs – Ana Coan (Brazil)
• Management of Childhood SeLFEs - what is the evidence? – Julia Jacobs-LeVan (Canada)

Challenge Session 5

Session title: What is Late-Onset Epilepsy? From Controversy to Consensus
Co-chairs: Vineet Punia (USA) and Ifrah Zawar (Pakistan/USA)

• Current concepts, controversies and operational definitions of Late-onset epilepsy in the literature – Vineet Punia (USA)
• Late-onset epilepsy around the world: Insights on variability in the diagnostic and management practices from an international survey – Rohit Marawar (USA)
• Psychiatric comorbidities of late-onset epilepsy – Evidence and burden of the hidden iceberg – Heather Angus-Leppan (United Kingdom)
• Chicken or the Egg Debate? The bidirectional borderlands of late-onset epilepsy and neurodegeneration – Terry O’Brien (Australia) and Ifrah Zawar (Pakistan/USA)

Controversial Discussion Session 1

Session title: Is Intracranial EEG Necessary in Lesional Epilepsy for Resective or Neuromodulation Procedures?
Co-chairs: Michael Sperling (USA) and Faisal Alotaibi (Saudi Arabia)

• Introduction – Michael Sperling (USA)
• Personal experience with SEEG – Sandra FerreiraI (Portugal)
• EEG is necessary to define the epileptogenic zone even when MRI, clinical symptoms, semiology, and scalp EEG are concordant – Fabrice Bartolomei (France)
• Intracranial EEG is not necessary to define the epileptogenic zone when MRI, clinical symptoms, semiology, and scalp EEG are concordant – Michael Sperling (USA)
• Is intracranial EEG needed prior to performing neuromodulation procedures? – Joon Kang (USA)

Controversial Discussion Session 2

Session title: SUDEP again? Yes, it is not yet solved!
Co-chairs: Lisa Bateman (USA) and Francisco Sales (Portugal)

• Voices from Loss: Understanding the Needs of Those Bereaved by SUDEP – Gardiner Lapham (USA)
• Rethinking SUDEP: Towards a Unified Classification – Roland Thijs (Netherlands)
• Deciphering SUDEP Pathways: Unveiling Mechanisms of Death – Shobi Sivathamboo (Australia)
• Bridging Bench to Bedside: Insights from Animal Models – Bin Gu (USA)
• Targeting SUDEP Risk: Advances in Pharmacotherapy – Pasquale Striano (Italy)

Controversial Discussion Session 3

Session title: Understanding Status Epilepticus in Developmental and Epileptic Encephalopathies (DEEs): A Comprehensive Exploration
Co-chairs: Nicola Specchio (Italy) and Ingrid Scheffer (Australia)

• Living with the fear of Status Epilepticus: the patient perspective – Isabella Brambilla (Italy)
• Exploration of the Clinical and Physiological Aspects of Status Epilepticus in DEEs – Elaine Wirrell (USA)
• The incidence and clinical manifestations of status epilepticus in channelopathies – Marina Trivisano (Italy)
• How significantly does status epilepticus contribute to neurological damage in patients with DEEs? – J Helen Cross (United Kingdom)

Controversial Discussion Session 4

Session title: Updates in the treatment of neonatal seizures: exploring controversies on definition and targeted approach
Co-chairs: Magda Lahorgue Nunes (Brazil) and Sofia Quintas (Portugal)

• Neonatal EEG Monitoring: Indications, Approach, and Management – Nicholas Abend (USA)
• Do we still have controversies regarding Neonatal Seizures? An introduction to the topic – Ronit Pressler (United Kingdom)
• What is neonatal status epilepticus? – Magda Lahorgue Nunes (Brazil)
• What are clues to determine etiology of acute provoked seizures? – Elissa Yozawitz (USA)
• How we can use etiologically targeted approaches in the treatment of neonatal seizures? – Hans Hartmann (Germany)

Controversial Discussion Session 5

Session title: What is the relationship between hormones, epilepsy and antiseizure medications?
Co-chairs: Bruna Nucera (Italy) and Nathalie Jette (Canada)

• What is the relationship between reproductive hormones and epilepsy? Sex and hormonal influences on seizures and epilepsy – Erik Taubøll (Norway)
• Hormonal therapy for epilepsy: progesterone and its derivatives for the treatment of catamenial epilepsy – Bruna Nucera (Italy)
• Reproductive health in people with epilepsy: infertility and fertilization techniques – Barbara Mostacci (Italy)
• What do we know about epilepsy care in transgender patients with epilepsy? – Emily Johnson (USA)
• Facing the unknown: Pregnancy, hormones and epilepsy – Emma Lovise Larsen (Norway)

Controversial Discussion Session 6

Session title: Controversies for the epileptologist in the ICU
Co-chairs: Andrea Rossetti (Switzerland) and Elan Guterman (USA)

• Use general anesthetics promptly in SE ("early is better") – Adam Strzelczyk (Germany)
• rEEG is as good as cEEG (“less is more”) – Andrea Rossetti (Switzerland)
• cEEG is more efficient than rEEG (“more is better”) – Pia De Stefano (Switzerland)
• Use general anesthetics parsimoniously in SE (“late is better”) – Elan Guterman (USA)

Parallel Session 1

Session title: Can real word practice impact the knowledge about antiseizure medications?
Co-chairs: Vicente Villanueva (Spain) and Jose Angel Aibar (Spain)

• Pros and cons of real world data and randomized control trials – Simona Lattanzi (Italy)
• The informative role of pregnancy registries in clinical practice – Torbjörn Tomson (Sweden)
• Real world data in Developmental and Epileptic Encephalopathies – Adam Strzelczyk (Germany)
• Data generation in elderly and people with comorbidities – Vicente Villanueva (Spain)
• Patients’ perspective of real-world data studies – Jose Angel Aibar (Spain)

Parallel Session 2

Session title: Cardiac disease in epilepsy – getting to the heart of the ‘Epileptic Heart’
Co-chairs: Colin Josephson (Canada) and John Dunne (Australia)

• Causes and consequences of cardiac disease in epilepsy – Elizabeth Donner (Canada)
• Treating epilepsy: unraveling the associations between antiseizure medications and cardiovascular disease – Samuel Terman (USA)
• Monitoring for cardiac disease in epilepsy conventional and emerging approaches – Shobi Sivathamboo (Australia)
• Sudden cardiac death: a cause of SUDEP or etymological fallacy? – Colin Josephson (Canada) and Roland Thijs (Netherlands)
• Patient and provider perspective: when and how should the risk of cardiac disease and sudden cardiac death be conveyed – Samuel Wiebe (Canada) and Gardiner Lapham (USA)

Parallel Session 3

Session title: Family Planning in Drug-resistant epilepsies.
Co-chairs: Manuel Toledo (Spain) and Ching Soong Khoo (Malaysia)

• Defeating the stigmas in women of childbearing potential with drug-resistant epilepsy – Elvira Vacas Montero (Spain)
• Contraception and things to do before the pregnancy in drug-resistant epilepsy – Denise Li (USA)
• Best therapeutic medical options for women of childbearing potential with drug-resistant epilepsy – Torbjörn Tomson (Sweden)
• Precision medicine and relevance of genetics for family planning in epilepsy – Estefania Conde (Spain)
• Between Seizures and Support – My Road to Parenthood – Emma Lovise Larsen (Norway)

Parallel Session 4

Session title: New insights for non-invasive and invasive neuromodulation techniques
Co-chairs: Antonio Valentin (United Kingdom) and Guy McKhann (USA)

• Cathodal Transcranial Direct-Current Stimulation in Epilepsy – Daniel Sanjuan (Mexico)
• Subacute (SCS) and chronic cortical stimulation (CCS) for epilepsy treatment – Antonio Valentin (United Kingdom)
• The clinical value of TMS-EEG in epilepsy – Vasilios Kimsikidis (Greece)
• Cortical stimulation for epilepsy: target the focus or the network? – Dorien van Blooijs (Netherlands)

Parallel Session 5

Session title: Recent progress in molecular neuroimaging for epilepsy
Co-chairs: Daichi Sone (Japan) and Jaideep Kapur (USA)

• Glutamate receptor imaging in epilepsy – Marian Galovic (Switzerland)
• Molecular neuroimaging for comorbidities in epilepsy – Matthias Koepp (United Kingdom)
• Neuroinflammation imaging for epilepsy: PET and MRS findings – Jerzy Szaflarski (USA)
• Blood-brain barrier imaging for epilepsy – Maria Ilyas-Feldmann (Germany)

Parallel Session 6

Session title: Reconceptualising Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis – Understanding Genetic and Acquired Contributions
Co-chairs: Michael Hildebrand (Australia) and Norman Delanty (Ireland)

• Interactive Introduction to MTLE+HS including Audience Live QR Code Survey – Ingmar Blümcke (Germany)
• Living with MTLE+HS: A journey through drug-resistance and epilepsy surgery – Petra Naydenov (Portugal) and Michaela-Pauline Lux Germany)
• Clinical phenotypes and risk factors of MTLE+HS – Sam Gooley (Australia)
• Role of acquired factors in MTLE+HS over the lifespan – Aristea Galanopoulou (USA)
• Role of genetic factors in MTLE+HS – Sattar Khoshkhoo (USA)

Parallel Session 7

Session title: The two sides of glia and epilepsy: the outside perspective
Co-chairs: Andrey Mazarati (USA) and Matthew Walker (United Kingdom)

• Glial regulation of neuronal function on cellular level: physiology and biochemistry – Milos Pekny (Sweden)
• Glial regulation of neuronal function of a network level: glymphatic system in health and disease – Lucy Vivash (Australia)
• Glial regulation of neuronal function on extracerebral level: the role of gut-brain axis – Andrey Mazarati (USA)
• Therapy perspective: development of personalized glioblastoma vaccines – Adilia Hormigo (USA)

Parallel Session 8

Session title: IGAP: From Adoption to Implementation
Co-Chairs: Francesca Sofia (Italy) and Alla Guekht (Russian Federation)

• IGAP: Overview and Update – Tarun Dua (Switzerland)
• IGAP in The Americas: Focus in Argentina – Keryma Acevedo (Chile) and Maria Marta Bertone (Argentina)
• IGAP in Africa: Introducing the African Trendsetters leading IGAP implementation actions – Enat Yewnetu (Ethiopia)
• IGAP in Europe: EpiAlliance – IGAP Consensus and Implementation Plan in Spain – Jose M. Serratosa (Spain) and Elvira Vacas Montero (Spain)
• IGAP in Asia Oceania: Implementing IGAP Policy Initiatives in Asia Oceania – Focus on The Philippines – Leonor Cabral-Lim (Philippines)
• IGAP in Asia Oceania: Implementing IGAP Policy Initiatives in Asia Oceania – Progress in Australia – Piero Percca (Australia) 
• Panel Discussion and Audience Q&A 
• Closing Speech – IGAP – Call to Action – Roberto Caraballo (Argentina)

Parallel Session 9

Session title: Have less invasive surgical techniques and improved mapping of eloquent functions reduced the risks associated with epilepsy surgery?
Co-chairs: Meneka Sidhu (United Kingdom) and Takamichi Yamamoto (Japan)

• Risks associated with resective vs minimally invasive techniques for treating refractory focal epilepsy – Michele Rizzi (Italy)
• Advances in functional imaging in the mapping of presurgical eloquent functions – Meneka Sidhu (United Kingdom)
• White matter matters: Advances in the mapping of white matter tracts to reduce the risk of cognitive decline – Davide Giampiccolo (Italy)
• Incorporating advanced imaging sequences to mitigate the risks of epilepsy surgery- worked examples – Jorge Gonzalez-Martinez (USA)
• PPIE: Lived Example- Right temporal DNET – Christopher Hallatt Wells (United Kingdom)

Solutions Session 1

Session title: Advancing the role of the pharmacist in the care and management of the patient with epilepsy
Co-chairs: H Steve White (USA) and Cecilie Johannessen-Landmark (Norway)

• The pharmacist's role in bridging the gap in healthcare access in epilepsy: a patient's perspective – Matthew Attard (Malta)
• The development of an asynchronous and synchronous epilepsy management training program for the community pharmacist – Michelle Guignet (USA)
• Experience from a Pharmacology team at a national epilepsy center to improve patient treatment, Inter-professional collaboration, education and research – Cecilie Johannessen-Landmark (Norway)
• Role of the Clinical Pharmacist Practitioner in Epilepsy Ambulatory Care: Perspectives from a US Veterans Administration Epilepsy Center of Excellence – Barry Gidal (USA)
• How pharmacists are improving access to care and antiseizure medications in low resource countries – Anne Anokye (Ghana)

Solutions Session 2

Session title: Consensus terminology for functional dissociative seizures
Co-chairs: W Curt LaFrance Jr (USA) and Francisca Sá (Portugal)

• Terminology: Why for Functional? – Markus Reuber (United Kingdom)
• Terminology: Why for Dissociative? – Deniz Ertan (France)
• Terminology: Why for Seizure? – Chrisma Pretorius (South Africa)
• Terminology: Why not Psychogenic? – W Curt LaFrance Jr (USA)
• Public Involvement: Patient Perspective – Peter Gilli (USA)

Solutions Session 3

Session title: Mitigating the global treatment gap in pediatric epilepsy
Co-chairs: Jitendra Kumar Sahu (India) and Jo Wilmshurst (South Africa)

• Treatment gaps in pediatric epilepsies- Global unmet needs – Francesca Sofia (Italy)
• Mitigating treatment lag for infantile epilepsy in LMICs: IESS Model – Priyanka Madaan (India)
• Real life examples of missed and delayed diagnosis with patient experience videos – Sameer Zuberi (United Kingdom)
• Telehealth Epilepsy Smart School Model in India: An innovative model – Sulena Sulena (India)
• How can we minimize mortality in developmental and epileptic encephalopathies? – Jo Wilmshurst (South Africa)

Solutions Session 4

Session title: Plant-based medicines: Development from ethnopharmacology to evidence-based medicine

Co-chairs: Siegward Elsas (Switzerland) and Lieven Lagae (Belgium)

• A Patient's Perspective on the Therapeutic Potential of Cannabidiol – Ariane Orosz (Switzerland)
• Cannabinoids in epilepsy; the journey – Kate Riney (Australia)
• Huperzine A: Back to the Future – Siegward Elsas (Switzerland)
• Identification of new epilepsy drug candidates from medicinal plants using zebrafish models
• – Camila Esguerra (Norway)
• Palmatine and 6-gingerol – new candidates for anticonvulsant drugs? – Kinga Gawel (Poland)

Solutions Session 5

Session title: Self-stigma and psychoeducation in epilepsy
Co-chairs: Daichi Sone (Japan) and Honor Coleman (Australia)

• Epilepsy self-stigma scale and one-day psychoeducation “Epi-School” in Japan – Izumi Kuramochi (Japan)
• Perceived and self-stigma in people with epilepsy in Africa – Musa Mamman Watila (Nigeria/UK)
• Self-stigma, psychiatric problems, and psychoeducation in people with epilepsy in Australia – Honor Coleman (Australia)
• Self-stigma and psychoeducation in Germany and the role of MOSES – Anne Hagemann (Germany)

Solutions Session 6

Session title: When the Inevitable Happens: Addressing the needs of people with epilepsy during disasters and emergencies
Co-chairs: Timothy Welty (USA) and Olha Tychkivska (Ukraine)

• Epilepsy and Disasters: An overview on the scope of the problem – Timothy Welty (USA)
• Planning and preparing through government and public health engagement – Jean Marie Ahorro (Philippines)
• Training first responders in seizures and epilepsy – Archana Patel (USA)
• Effective responses to disasters and emergencies – Timothy Welty (USA)
• Continuous improvement of emergency responses – Manuel Tomas Mesa Latorre (Chile)
• Left Behind: Amplifying the Voices of People with Epilepsy in Disasters and Humanitarian Crises – Action Amos (Malawi)

Solutions Session 7

Session title: Identifying and addressing global gaps in access to genetic testing for the epilepsies
Co-chairs: Iscia Lopes-Cendes (Brazil) and Gaetan Lesca (France)

• Introduction & Lived experience testimonies from different ends of the globe – Iscia Lopes-Cendes (Brazil)
• The ‘diagnostic gap’ - Global reality of genetic testing. Insights from the 2023-2024 worldwide ILAE survey on genetic testing – Andreas Brunklaus (United Kingdom)
• Challenges in providing genetic services among children and adults in low- and middle-income countries – Myriam Essid (Tunisia)
• Pragmatic testing pathways – Enabling genetic testing for the epilepsies in South Africa – Alina Esterhuizen (South Africa)
• The power of collaboration – Building research and education alliances to empower local genetic testing opportunities in LMICs – Chahnez Triki (Tunisia)

Full Day Teaching Course

Teaching Course Title: Neuroimaging in epilepsy — what the clinician should know

Chair: Anna Elisabetta Vaudano (Italy)

• Introduction to neuroimaging in epilepsy – Anna Elisabetta Vaudano (Italy)
• MRI physics, sequence names, and MRI epilepsy protocol – Felice D'Arco (United Kingdom)
• MRI protocol and hints for neonates and infants – Stefan Rampp (Germany)
• Common epileptic pathologies: temporal epilepsy – Angelo Labate (Italy)
• Common epileptic pathologies: extratemporal lobe epilepsy – Britta Wandschneider (United Kingdom)
• MRI-negative epilepsy. What are the next steps? – Boris Bernhardt (Canada)
• Other neuroimaging modalities: PET, SPECT, ASL – Lorenzo Caciagli (Italy)
• fMRI (task-based) & EEG-fMRI – Paolo Federico (Canada)
• Diffusion imaging, presurgical image fusion – Fernando Cendes (Brazil)

Half Day Teaching Courses

AM Teaching Course Title: Neonatal EEG boot camp

Co-Chairs: Ronit Pressler (United Kingdom) and Monika Eisermann (France)

• EEG in neonates: How do I record a better EEG? – Rachel Thornton (United Kingdom)
• Normal EEG in Neonates – Sushma Goyal (United Kingdom)
• EEG Biomarkers of Acute Brain Injury in Neonates– Geraldine Boylan (Ireland)
• Neonatal seizures – Ronit Pressler (United Kingdom)
• Epilepsy with onset in the neontal period – Monika Eisermann (France)

AM Teaching Course Title: Patient and Public Involvement in Epilepsy Research

Co-chairs: Reetta Kälviäinen (Finland) and Marie Ennis O’Connor (Ireland)

• Definitions, role and impact of PPI in epilepsy research – Reetta Kälviäinen (Finland)
• Fostering PPI for clinical trials with case examples – Jacqueline French (USA)
• Fostering PPI through co-design in seizure detection and monitoring technologies with case examples – Torie Robinson (United Kingdom)
• IBE role in building the knowledge and skills for PPI in epilepsy – Eli Cripps (Ireland)

PM Teaching Course Title: Optimizing pharmacotherapy in epilepsy. Which ASM to start with? When to stop?

Co-Chairs: Torbjörn Tomson (Sweden) and Stephane Auvin (France)

• First ASM for children – Stéphane Auvin (France)
• First ASM for adults – Anthony Marson (United Kingdom)
• Uptitration and dose optimization – Torbjörn Tomson (Sweden)
• Strategy when 1st monotherapy fails switch or add-on a debate – Anthony Marson (United Kingdom) and Jacqueline French (USA)
• Which ASM to consider if 1st monotherapy fails – Jacqueline French (USA)
• What is the role of the newest ASMs? – Michael Sperling (USA)
• Stopping ASM treatment in seizure free adults – Torbjörn Tomson (Sweden)
• Stopping ASM treatment in seizure free children – Stéphane Auvin (France)

PM Teaching Course Title: Let’s read EEGs together!

Chair: Sándor Beniczky (Denmark)

• Systematic approach to EEG reading. Background activity and interictal abnormalities – Sándor Beniczky (Denmark)
• Normal variants and artefacts – Fabio Nascimento (USA)
• Ictal patterns – Margitta Seeck (Switzerland)
• Electroclinical correlations in epilepsy syndromes – Dana Craiu (Romania)

PM Teaching Course Title: Clinical and genetic diagnostics of epilepsy syndromes

Co-chairs: Guido Rubboli (Denmark) and Ingrid Scheffer (Australia)

• Clinical and genetic diagnosis of epilepsy syndromes – where to start? – Ingrid Scheffer (Australia)
• Genetic testing in epilepsy – which patients, which tests, and which yields in the clinics? – Guido Rubboli (Denmark)
• The interplay of rare and common variants in the genetic architecture of the epilepsies – Karen Oliver (Australia)
• “Precision medicine” in genetic epilepsies: hype or hope? – Amy McTague (England)
• Gene therapy in Dravet syndrome: are we there yet? – Andreas Brunklaus (Scotland)

PM Teaching Course Title: Status epilepticus

Co-Chairs: Eugen Trinka (Austria) and Aidan Neligan (United Kingdom)

• Definition, classification and causes – Eugen Trinka (Austria)
• Diagnosis of SE – Neurophysiology and Neuroimaging – Pilar Bosque Varela (Austria)
• Management of early and established SE – Camilo Espinoza Jovel (Columbia)
• Treatment of refractory and super-refractory SE – Aidan Neligan (United Kingdom)

PM Teaching Course Title: Epilepsy surgery: learn from cases!

Co-chairs: Philippe Kahane (France) and Philippe Ryvlin (Switzerland)

• Video-EEG in Presurgical Evaluation: A Critical Tool for Surgical Planning – Philippe Kahane (France)
• Unmasking Non-Lesional Epilepsy: Key Techniques and Tips for Detecting Lesions – Jörg Wellmer (Germany)
• SEEG-Informed Epilepsy Surgery: Essential Do’s and Don’t’s – Birgit Frauscher (USA)
• Mastering Pediatric Epilepsy Surgery: Expert Pearls for Success – Julia Jacobs-LeVan (Canada)
• Personalized Treatment: When to Choose Resection or Ablation? – Jorge Gonzalez-Martinez (USA)
• Role of neuromodulation in epilepsy surgery – Philippe Ryvlin (Switzerland)

Teaching Session Title: VIREPA Basic & Advanced EEG

• Exploring the EEG fundamentals: an introduction to the VIREPA Basic EEG course – Elena Gardella (Denmark)
• EEG in the diagnosis & management of epilepsy Advance Course – Antonio Valentin (United Kingdom)

Teaching Session Title: VIREPA Paediatric EEG & VIREPA MRI

• VIREPA Paediatric EEG – Monika Eisermann (France)
• VIREPA MRI – Stefan Rampp (Germany)

Teaching Session Title: Advanced EEG: source imaging – Part 1 (Theory)

• Basic biophysical principles of source estimation: from current dipoles to voltage maps – Sándor Beniczky (Denmark)
• Clinical implementation of EEG source imaging: why, what and how? – Stefan Rampp (Germany)

Teaching Session Title: Advanced EEG: source imaging – Part 2 (Hands-on)

• Source imaging cases – Sándor Beniczky (Denmark)
• Source imaging cases – Stefan Rampp (Germany)

Teaching Session Title: Teaching Session: MEG
Co-chairs: Sándor Beniczky (Denmark) and Stefan Rampp (Germany)

• Basic principles of MSI: flux-maps, source-space and averaging – Sándor Beniczky (Denmark)
• Inverse solutions and reporting – Stefan Rampp (Germany)
• Cases and examples of MSI – Sándor Beniczky (Denmark) and Stefan Rampp (Germany)

Teaching Session Title: Video Session - Seizure semiology in Paediatric Epilepsies

• Seizure semiology in neonates – Ronit Pressler (United Kingdom)
• Seizure semiology in children with generalized epilepsies – Nicola Specchio (Italy)
• Focal seizures semiology. Is it the same as in adults? – Alexis Arzimanoglou (Spain)

Teaching Session Title: Video session – Challenges in diagnosis
Chair: Guido Rubboli (Denmark)

• Myoclonus and myoclonic seizures – Guido Rubboli (Denmark)
• Nocturnal events – Matthew Walker (United Kingdom)
• Posterior quadrant seizures – Laura Tassi (Italy)

Teaching Session Title: The relevance of animals’ models in epilepsy research and drug discovery

• The relevance of animal models of seizures or epilepsies in drug discovery – Aristea Galanopoulou (USA)
• Mechanisms of focal seizure generation: preclinical studies based on human EEG findings – Marco de Curtis (Italy)

Teaching Session Title: Immunity, inflammation and epilepsy
Chair: Jeffrey Britton (USA)

• Update in treatment and surgery in Rasmussen syndrome – Tiziana Granata (Italy)
• Clinical, EEG and imaging presentations of autoimmune encephalitides in adults – Jeffrey Britton (USA)
• Autoimmune mechanisms in seizure disorders – Christian Geis (Germany)
• FIRES in children: unraveling etiology, current treatment, and management strategies – Sara Matricardi (Italy)

Teaching Session Title: Developmental and Epileptic encephalopathies
Chair: Alexis Arzimanoglou (Spain)

• What are developmental and epileptic encephalopathies? – Ingrid Scheffer (Australia)
• Holistic care of patients with DEEs – far more than seizure disorders – Federico Vigevano (Italy)
• The path to precision management of DEEs – J Helen Cross (United Kingdom)

Special Interest Session 1

Session title: New Challenges and Progress in Treatment of Inherited Metabolic Epilepsies

Chair: Philip Pearl (USA) and Alicia Bogacz (Uruguay)

• New Approaches to Inherited Metabolic Epilepsies – Phillip Pearl (USA)
• Clinical Trials for Inherited Metabolic Epilepsies: Plans and Pitfalls – William Theodore (USA)
• Biomarker Development in Inherited Metabolic Epilepsies – Alexander Rotenberg (USA)
• Inducible Models for Gene Therapy in Inherited Metabolic Epilepsies – Hingcheong Lee (Hong Kong)

Special Interest Session 2

Session title: Blood biomarkers in epilepsy: state of the art and potential clinical application

Chair: Johan Zelano (Sweden)

• Blood biomarkers in epilepsy: an overview and potential applications: prediction, diagnosis, and monitoring of treatment and drug safety – Johan Zelano (Sweden)
• Plasma Tau and cognitive function in late onset epilepsy – Rani Sarkis (USA)
• Neurofilament and other blood biomarkers in status epilepticus – Stefano Meletti (Italy)
• Blood tests to predict epilepsy after stroke and other brain lesions – Laura Abraira (Spain)
• Panel discussion including the audience: Where now with blood tests in epilepsy? The audience is encouraged to participate and share ongoing research initiatives, studies, or ideas.

Special Interest Session 3

Session title: Epilepsy and neurodevelopmental comorbidities of SLC6A1-related disorders

Chair: Vincenzo Crunelli (United Kingdom)

• Parenting siblings with SLC6A1 mutations and strategy of patient organisations – Lindsay Randall (United Kingdom)
• From genotype to protein structure to phenotype in SLC6A1-related disorders – Dennis Lal (USA)
• Non-seizure characteristics of SLC6A1-related neurodevelopmental disorders – Katrine Marie Johannesen (Denmark)
• SLC6A1 function in health and disease using GABASnFR – Chris Dulla (USA)
• Targeting astrocytic GAT1 dysfunction rescues absence seizures and their comorbidities – Tatiana Morais (Portugal)

Special Interest Session 4

Session title: The enigmatic structure: Amygdala enlargement in epilepsy

Co-Chairs: Daichi Sone (Japan)

• Multimodal neuroimaging findings in epilepsy with amygdala enlargement – Daichi Sone (Japan)
• Amygdala subnucleus: the role and volumetric analysis in epilepsy – Anna Vaudano (Italy)
• Neural plasticity and amygdala enlargement in epilepsy – Marian Galovic (Switzerland)
• Amygdala enlargement and sudden unexpected death in epilepsy (SUDEP) – Beate Diehl (United Kingdom)

Special Interest Session 5

Session title: Developmental and Epileptic Encephalopathies: From Bed to Benchside and Back

Chairs: Kette Valente (Brazil) and Ana Borg (USA)

• The Roadmap to Make Developmental and Epileptic Encephalopathies Tractable and Attractive - Andreas Borg (USA)
• Best Practices in Developmental and Epileptic Encephalopathies Management: Must the Better be the Enemy of the Good?
  • Centers of Excellence are Needed – Scott Demarest (USA)
  • Minimum Viable Centers are Mandatory – Ángel Aledo-Serrano (Spain)
  • Rebuttal and Conclusion: Do we have a middle ground? — Scott Demarest (USA) and Ángel Aledo-Serrano (Spain)
• Challenges for Clinical Trials Readiness in Multisystemic Disorders with DEEs. Delineating New Scales – Pros and Cons
  • Delineating New Scales – Pros and Cons – Jenny Downs (Australia)
  • Validating and Adapting Existing Scales – Pros and Cons – Xavier Liogier d'Ardhuy (France)
  • Rebuttal and Conclusion: Do we have a winner? – Jenny Downs (Australia) and Xavier Liogier d'Ardhuy (France)
• The Future of DEE Treatments: Personalized vs Precision
  • Personalized Medicine: making the best out of what we have today – Kette Valente (Brazil)
  • Precision Medicine: getting the most out of science – Ana Mingorance (Spain)
  • Rebuttal and Conclusion: Does one thing rule out the other? – Kette Valente (Brazil) and Ana Mingorance (Spain)

Special Interest Session 6

Session title: From Awkward to Empowered: Having truly 'patient-centered' conversations in epilepsy care and research

Chair: Milena Gandy (Australia)
 

• Patient and Family Perspectives – Torie Robinson (United Kingdom)
• Neurologist / Epileptologist Perspectives – Heidi Munger Clary (USA)
• Psychologist Perspectives – Milena Gandy (Australia)
• Young Epileptologist Perspectives – Brad Kamitaki (USA) and Lucas Orellana (Argentina)

Special Interest Session 7

Session title: Acute Symptomatic Seizures: time to reconsider definitions and management?

Chair: Marian Galovic (Switzerland)

• Controversy 1: The current definition of acute symptomatic seizures is adequate – Marian Galovic (Switzerland)
• Controversy 1: The current definition of acute symptomatic seizures needs revising – Eugen Trinka (Austria)
• Controversy 2: Acute symptomatic seizures do not require treatment – Carla Bentes (Portugal)
• Controversy 2: Acute symptomatic seizures should be treated – Vineet Punia (USA)
• Summary and take-home message – Ronit Pressler (United Kingdom)

Special Interest Session 8

Session title: Strengthening the Capacity of the Non-Specialist Workforce to Improve Epilepsy Care

Co-Chairs: Martin Kirkpatrick (United Kingdom) and Gagandeep Singh (India)

• Non-Specialist Workforce Training and the IGAP – J Helen Cross (United Kingdom)
• How healthcare worker training improves patients' lives – Enat Yewnetu (Ethiopia)
• 20 years of PET - what has been achieved around the world? – Jo Wilmshurst (South Africa)
• PET in Brazil - successes and challenges – Marilisa Guerreiro (Brazil)
• Taking a coordinated approach to training across the paediatric and adult workforces – MV Gule (South Africa)

Special Interest Session 9

Session title: The Dual Relationship Between Dementia and Seizures: Clinical and Epidemiological Perspectives

Chair: Francesco Brigo (Italy)

• Deciphering the Complex Interplay Between Dementia and Seizures – Francesco Brigo (Italy)
• From dementia to seizures: epidemiological and clinical challenges – Laura Abraira (Spain)
• From seizures to dementia: epidemiological and clinical challenges – Johan Zelano (Sweden)
• Case Studies – Laura Abraira (Spain), Johan Zelano (Sweden) and Francesco Brigo (Italy)

Special Interest Session 10

Session title: SEEG in young children. ''Build your implantation scheme''

Chair: Mathilde Chipaux-Raffo (France)

• SEEG in children with spasms- epileptologist perspective – Emmanuel Raffo (France)
• SEEG in young children with Tuberous Sclerosis Complex- Epileptologist Perspective – Manjari Tripathi (India)
• SEEG when eloquent cortex is involved – Andrea Andrade (Canada)

Special Interest Session 11

Session title: Transition from pediatric to adult care: Access to all?

Chair: Danielle Andrade (Canada)

• The real-world experience of moving from pediatric to adult care: patient and health care perceptions – Quratulain Zulfiqar-Ali (Canada)
• How transition is done (or not done) in 58 countries: A global survey of the ILAE transition task force – Danielle Andrade (Canada)
• What young patients think about transition of care before and after leaving the pediatric system? – Jaime Carrizosa (Colombia)
• Barriers for transition: differences between barriers perceived by low, medium and high-income countries – Jo Wilmshurst (South Africa)
• How to empower patients and families to improve transition for all – Rima Nabbout (France)

Special Interest Session 12

Session title: Mortality in DEEs across the lifespan: Timing, Causes and Prevention

Chair: Danielle Andrade (Canada)

• Epidemiology and risk factors for mortality in DEEs – Jose Aibar (Spain) and Rima Nabbout (France)
• Genetic mutations in shaping mortality risk – Ingrid Scheffer (Australia)
• Mechanisms and predictors of death in children and adults with DEEs – Danielle Andrade (Canada)
• Discussing mortality with families – Kette Valente (Brazil)
• How should we handle mortality in children and adults with DEE: is there a role for palliative care? – Victor Lira (Canada)

Special Interest Session 13

Session title: Climate change and epilepsy from the perspective of carbon footprint

Chair: Medine Gulcebi Idriz Oglu (Turkey)

• Carbon footprints of participants from different countries to join the special interest session – Priyanka Madaan (India)
• The latest research breakthroughs about the effects of extreme weather events on epilepsy – Francesco Fortunato (Italy)
• Practical tips for patients and clinicians to mitigate adverse consequences of climate change and to reduce carbon footprint – Patrick Moloney (Ireland)
• Carbon footprint of health sector and research – James Mills (Netherlands)

Special Interest Session 14

Session title: SUDEP & Seizure safety counselling: A tale of six countries

Chair: Rohit Shankar (United Kingdom)

• An evidence-based approach to develop SUDEP surveys – Rohit Shankar (United Kingdom)
• SUDEP counselling: tales from UK & Ireland – Rohit Shankar (United Kingdom)
• SUDEP counselling: tales from Norway – Oliver Henning (Norway)
• SUDEP counselling: tales from Sweden – Torbjorn Tomson (United Kingdom)
• SUDEP communication: tales from Hungary – Anna Kelemen (Hungary)
• SUDEP counselling: tales from Spain – Vicente Villanueva (Spain)

Special Interest Session 15

Session title: Turning Challenges into Solutions: Advancing Epilepsy Care Together

Chair: Katharina Moser (Austria) and Alison Kukla (USA)

• Challenges and Priorities in Epilepsy Care: Setting the Stage – Katharina Moser (Austria)
• From Challenges to Solutions: Global Perspectives from Young Voices – Alison Kukla (USA)
• Panel 1: Overcoming Global Implementation. Challenges: A Collaborative Exchange – Maria Marta Bertone (Argentina), Ana Suller Marti (Canada), and Sanja Gluscevic (Montenegro)
• Panel 2: From Vision to Reality: Turning. Strategies into Practice – Emma Lovise Larsen (Norway), David Asish Manchala (India), and Sally Shaaban (Egypt)

Special Interest Session 16

Session title: Actions to Reduce the Burden of Caregivers of People with Epilepsy Across the World

Chair: Elvira Vacas (Spain)

• The Burden of Caregivers of People with Epilepsy Around the World – Manuel Toledo (Spain)
• Actions to Reduce the Burden of Caregivers Across the World – Anchor Hung (Hong Kong)
• Actions to Reduce the Burden of Caregivers Across the World – Maria Marta Bertone (Argentina)
• Actions to Reduce the Burden of Caregivers Across the World – Laura Weidner (USA)

Special Interest Session 17

Session title: Ablation in epilepsy surgery – different approaches in different syndromes – Is this justified?

Chair: Friedhelm C Schmitt (Germany)

• Hypothalamic Hamartoma – stereotactic laser thermoablation – Daniel J Curry (USA)
• Hypothalamic Hamartoma – radiofrequency thermoablation – Hiroshu Shirozu (Japan)
• Hypothalamic Hamartoma – MRIguided Focus Ultrasound – John Ragheb (USA)
• Hypothalamic Hamartoma – the "classical" endoscopic approach – Wirginia Maixner (Australia)
• Mesial Temporal Lobe Epilepsy - stereotactic laser thermoablation – Friedhelm C Schmitt (Germany)
• MTLE – SEEguided-radiofrequency-thermoablation – Stéphane Jean (China)
• MTLE – the "classical" resective approach" – Kostas N. Fountas (Greece)

Special Interest Session 18

Session title: Aetiology-Specific Spectrum of Epilepsy Syndromes: Redefining Diagnosis and Management

Chair: Nicola Specchio (Italy)

• The Evolution of Epilepsy Classification: Overview of Etiology-Specific Epilepsy Syndromes and their impact on clinical practice – Nicola Specchio (Italy)
• Bridging Genetics, Imaging, and Functional effect – Ingrid Scheffer (Australia)
• Should Etiology Drive Classification in All Settings? – Stephane Auvin (France)
• Addressing Global Challenges in ESSE Implementation – Jo Wilmshurst (South Africa)

Special Interest Session 19

Session title: The Economics of Epilepsy (EOE) in the IGAP era

Co-Chairs: Ding Ding (China) and Gagandeep Singh (India)

• Expenditure on epilepsy: a lay-persons perspective – Patricia Braga (Uruguay)
• The perspective of someone with drug-resistant epilepsy – Lara Jehi (USA)
• The perspective of a primary healthcare provider in resource-limited settings – Mashina Chomba (Zimbabwe)
• The perspective of a healthcare manager – Shivani Kalra (India)
• A policy-maker’s notes – Ryan Wegner (South Africa)

Special Interest Session 20

Session title: Epilepsy primary care debates: Second edition!

Chair: Gagandeep Singh (India)

• Is medicine access in high income countries ideal and can it be replicated in LMICs? – Ley Sander (United Kingdom)
• Medicine access in LMICs – what it really is and what can be done? – Arjune Sen (United Kingdom)
• One-time epilepsy care camps – Incredibly useful – Mamta Singh (India)
• Community health worker engagement in primary care – Jane von Gaudecker (USA)
• Community health worker engagement in primary care – impractical – Faith Mosha (Tanzania)

Special Interest Session 21

Session title: Revisiting drug-resistant epilepsy

Chair: Aristea Galanopoulou (USA)

• DRE – A clinician’s view – Emilio Perucca (Australia)
• DRE - A pharmacologist’s view – Heidrun Potschka (Germany)
• DRE - A geneticist’s view – Gabriele Lignani (United Kingdom)
• DRE - A moving target? – Luisa Rocha (Mexico)
• Living with DRE – Landis Wiedner (USA)

Special Interest Session 22

Session title: Equitable, ethical, and effective global AI solutions in epilepsy

Chair: Colin Josephson (Canada)

• AI in epilepsy - the putative benefits and risks – Lara Jehi (USA)
• AI to advance care in LMIC regions and the Epilespy Diagnostic Companion – Arjune Sen (United Kingdom)
• SCORE-AI and EPISAVE seizure detection– Sándor Beniczky (Denmark)
• A roadmap for global implementation of AI-based solutions in epilepsy – Colin Josephson (Canada) and TBC
• Panel discussion – All speakers

Adult Epileptology 1

Co-chairs: Ed Bertram (USA) and Silvia Abente (Paraguay)

• Seizures and epilepsy in untreated cerebral cavernous malformations: a prospective, population-based cohort study – Abel Clemens Adriaan Sandmann (Netherlands)
• Subclinical EEG patterns in patients with focal epilepsy predict the presence of clinically manifest seizures – Lorena Franco-Rubio (Spain)
• Leveraging MEG and sEEG to investigate the association between Small Sharp Spikes and epileptiform discharges in mesial temporal lobe epilepsy – Stephen P. Klaus (USA)
• The effects of music intervention on inhibitory control in frontal lobe epilepsy patients – Yongjun Li (China)
• Effect of Advancing Reperfusion Therapies in Post-Stroke Epilepsy – Catarina Guedes Vaz (Portugal)
• Mapping the structural connectome of temporal lobe epilepsy variants to improve surgical outcomes – Sami Obaid (Canada)

Adult Epileptology 2

Co-chairs: Eugen Trinka (Austria) and Cristine Cukiert (Brazil)

• Clinical subtypes and characteristics of sleep-related epilepsy: A real-world study – Jinqi Zhou (China)
• Neuroimaging correlates of epilepsy in neurodegenerative disorders – Ifrah Zawar (USA)
• Risk of epilepsy in people with and without dementia – A nationwide cohort study – Theresa Wimberley (Denmark)
• Redefining Acute Symptomatic Seizures: The Role of Timing in Predicting Recurrence After Stroke – Kai Michael Schubert (Switzerland)
• Long-Term Outcomes in Idiopathic Generalized Epilepsies: A Decade of Follow-Up in a Tertiary Adult Care Population – Rui Lopes (Portugal)
• Suicidality at epilepsy diagnosis predicts treatment resistance in newly diagnosed focal epilepsy – Sarah Barnard (Australia)

Basic Science

Co-chairs: Ching Soong Khoo (Malaysia) and Aristea Galanopoulou (USA)

• ELFN1 deficiency: Mechanistic basis of the neurodevelopmental disorder with expanding phenotypic spectrum – Amber Declève (Belgium)
• TBC1D24 and vATPase interplay in the brain: physiopathology of TBC1D24-related epilepsies – Antonio Falace (Italy)
• Shaping the future of epilepsy research in Europe: The ERN EpiCARE priorities – Sébile Tchaicha (Spain)
• Unravelling Neurodevelopmental Disruptions in Dravet Syndrome using a Patient-Derived Organoid Model – Snezana Maljevic (Australia)
• Transcriptome analysis revealed Bmal1 as a key regulator of circadian-driven neuroinflammation and epileptogenesis – Danielle Carmo Ferreira Bruno (Ireland)
• Involvement of the Orexinergic System in Absence Epilepsy: Developmental Dynamics of Orexin-A – Elif Tugce Erdeve (Turkey)

Clinical Neurophysiology

Co-chairs: Noel Plascencia (Mexico) and Ghaieb Bashar Mohamed Aljandeel (Iraq)

• The role of EEG in the prediction of post-stroke seizures – Kai Michael Schubert (Switzerland)
• EEG features in vanishing white matter disease: a retrospective analysis of pediatric and adult patients – Giulia Battaglia (Italy)
• Quantitative EEG and risk of post-stroke epilepsy following acute ischemic stroke – Sara Parreira (Portugal)
• An Investigation into the Accuracy of Interictal Epileptiform Discharges Source Localization Using Different Electrode Densities – Daniel Mansilla (Canada)
• Interictal scalp electroencephalography characteristics may predict cognitive decline in people with late-onset epilepsy – Lu Lu (China)
• Relationship Between Memory and Altered Consciousness in Focal Seizures: Aura as a Key Marker – Nuria Campora (Argentina)

Drug Therapy

Co-chairs: Elinor Ben-Menachin (Sweden) and Linda Dalic (Australia)

• Efficacy of azetukalner in Focal Onset Seizure (FOS) subtypes: Results from the double-blind, placebo controlled, phase 2b X-TOLE study – Emilio Perucca (Australia)
• Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results from the open-label LILAC and LILAC-2 studies – Kasia Dobrzynska (Switzerland)
• Cognitive effects of cenobamate as compared to perampanel: a cross-sectional multi-center study in 675 patients – Juri-Alexander Witt (Germany)
• Establishing the predictive validity of preclinical seizure models in generalized epilepsies: An extension of the Praxis Analysis of Concordance Framework – Lyndsey Anderson (USA)
• Cannabidiol inhibits neuroinflammation in kainic acid-induced epileptic mice by promoting TREM2 expression – Peng Zhang (China)

Epidemiology

Co-chairs: Nathalie Jette (Canada) and Angelina Kakooza (Uganda)

• Genetic testing practices across EpiCARE Centers: Insights from a multicenter survey – Rima Nabbout (France)
• Ultra-refractory epilepsy: The newly-described entity – Irena Dolezalova (Czechia)
• Emulating target trials of periconceptional supplementation of high-dose folic acid in women taking antiseizure medication on risk of major congenital anomalies using Nordic Registry data - A SCAN-AED study – Yuelian Sun (Denmark)
• New-onset epilepsy among children with status epilepticus as their first seizure: interim report from the SEED study – Umar Abba Sabo (Nigeria)
• The Impact of Folic Acid Supplementation on Epilepsy, Maternal and Fetal Outcomes in Chinese Pregnant Women with Epilepsy – Ammar Abdulaziz (China)

Epilepsy and Reproductive Health

Co-chairs: Torbjorn Tomson (Sweden) and Alison Kukla (USA)

• Infertility outcomes in valproate exposed and unexposed men with epilepsy or bipolar disorder: an international cohort study of real-world healthcare data – Gashirai K Mbizvo (United Kingdom)
• Pregnancy outcomes after in vitro fertilization in women with epilepsy on antiseizure medications: Prospective data from EURAP – Torbjorn Tomson (Sweden)
• Periconceptional Low-Dose vs. High-Dose Folic Acid Supplementation and Neurodevelopmental Outcomes in Children Exposed to Antiseizure Medications: Preliminary Findings from the Prospective Observational Norwegian Mother, father and Child cohort study (MoBa) – Marte Helene Bjørk (Norway)
• Antiseizure medication dose changes in pregnancy and postpartum: findings from MONEAD – Denise Li (USA)
• Blood concentrations vs. dose effects of fetal antiseizure medications on cognition and behavior in children of mothers with epilepsy – Kimford Meador (USA)

Epilepsy Surgery

Co-chairs: Georgia Ramantani (Switzerland) and P Sarat Chandra (India)

• Good versus severely impaired memory functioning more than 10 years after temporal lobe epilepsy surgery. How did the patients get there? – Eli B. Kyte (Norway)
• Hemispherotomy in the first year of life: safety, feasibility, complications and seizure outcome – A single-center experience – Mikolaj Pielas (Poland)
• Association between radiofrequency thermocoagulation volume in the epileptogenic zone and surgical outcomes in drug-resistant epilepsy – Thanomporn Wittayacharoenpong (Australia)
• The impact of implanting sentinel or electrodes contralateral to the hypothesized epileptogenic zone in stereoelectroencephalography – Ana Suller Marti (Canada)
• Dynamic brain functional networks to investigate protective mechanisms against epileptic seizures – Alessandra Burini (Italy)
• First-in-human long-term ictal recording with multiple implanted endovascular EEG devices, EP-01 – Yosuke Masuda (Japan)

Genetics

Co-chairs: Chahenaz Triki (Tunisia) and Raidah Al-Baradie (Saudi Arabia)

• Genetic testing of DNA obtained from stereoEEG electrodes – successes and pitfalls – Barbora Straka (Czechia)
• Clinical and genetic insights from a large cohort of individuals with SCN2A-related disorders – Sopio Gverdtsiteli (Denmark)
• Phenotypic spectrum of loss-of-function variants in the KCNA2 gene and genotype-phenotype correlation – Leonardo Affronte (Denmark)
• Regional somatic mosaicism in focal pediatric epilepsy - Westley Phillips (USA)
• Involvement of CACNA2D2 in developmental and epileptic encephalopathy through disruption of calcium channel functionality and synaptic function – Miriam Essid (Tunisia)
• Long-term Safety and Efficacy of Deoxycytidine/Deoxythymidine Combination Therapy in POLG-related Disorders – Kenneth A. Myers (Canada)

IGAP Implementation

Co-chairs: Gagandeep Singh (India) and Marian Galovic (Switzerland)

• A systematic review and meta-synthesis of integrated care for mental health In epilepsy by The ILAE Integrated Mental Health Care Pathways Task Force – Milena Gandy (Australia)
• Adolescence and epilepsy. Educational and promotional program through strategies towards reducing the stigma among teenagers at school – Francisco Astorino (Argentina)
• Epilepsy12 – Measuring and improving care for children with epilepsies, England/Wales, 2009-2023 – Colin Dunkley (United Kingdom)
• Navigating Diversity: Validating the Epilepsy Diagnostic Companion in a South African Context – Sarah Jacobs (South Africa)
• Implementation of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) in Kazakhstan: Progress, Challenges, and Future Directions – Leila Dairbayeva (Kazakhstan)
• Ground-Up Implementation of the WHO IGAP in Kenya: Community-Led Epilepsy Advocacy and Care – Patrick Ngechu (Kenya)

Late-Breaking Abstracts

Co-chairs: Christian Dorfer (Austria) and Melody Asukile (Zambia)

• Community Epilepsy Medical Camps in Kenya – Fred Kiserem (Kenya)
• Epilepsy-Related and All-Cause Health Care Resource Utilization After Initiation of Adjunctive Cenobamate Among Patients 65 and Older – Vineet Punia (USA)
• Bridging the Epilepsy Treatment Gap in India: A Mixed-Methods Study to Strengthen Primary Care Response through Task-Sharing – Srishti Verma (India)
• Artificial Intelligence driven Closed-Loop Devices in SUDEP Prediction and Prevention: Insights from Persons with Epilepsy and Caregivers – João Ferreira (Portugal)
• Obstructive Sleep Apnea in Late-Onset Epilepsy of Unknown Origin: Exploring a Potential Link in Older Adults – Giulia Pederzoli (Italy)

Mixed Topics

Co-chairs: Andreas Schulze-Bonhage (Germany) and Bertil Rydenhag (Sweden)

• Machine learning models applied to independent cortical folding variables distinguish TLE subgroups – Thais Maria Santos Bezerra (Brazil)
• Causal relationship between air pollution and epilepsy: A Mendelian randomization study – Hui Zhang (China)
• The burden of cumulative comorbidities in epilepsy – Ameliagh Terrins-Hutchinson (United Kingdom)
• Identification of distinct biological groups of patients with cryptogenic NORSE via inflammatory profiling – Aurelie Hanin (France)
• Progressive cortical and hippocampal atrophy after status epilepticus: a prospective longitudinal MRI study – Bernardo Crespo Pimentel (Austria)
• Real-World Use of Fenfluramine for Dravet Syndrome: a Retrospective Cohort Study Using a National Pharmacy Database – Elaine Wirrell (USA)

Neuroimaging

Co-chairs: John Duncan (United Kingdom) and Dave Clarke (USA)

• Multimodal investigation of the thalamus in children with temporal lobe epilepsy – Xiyu Feng (United Kingdom)
• Premature structural brain ageing and domain-specific cognitive changes in epilepsy – Heath Pardoe (Australia)
• Refining the radiological spectrum of GATOR1-related epilepsy – Chiara Pepi (Italy)
• Expanding language assessment in epilepsy patients through the individual functional connectome – Radheshyam Stepponat (Austria)
• Advanced Diffusion MRI Reveals Microstructural Alterations in Focal Cortical Dysplasia: Insights Beyond Conventional Imaging – Jakub Otáhal (Czechia)

Neuropsychology

Co-chairs: Colin Reilly (United Kingdom) and Sarah Wilson (Australia)

• Cognition is supported by the dynamic redistribution of information through brain networks: evidence from the Australian Epilepsy Project – Chris Tailby (Australia)
• The impact of clinical and demographic factors on trajectories of decline in verbal memory in people with focal epilepsy – Sallie Baxendale (United Kingdom)
• Hippocampal volume correlates negatively with episodic memory performance in newly diagnosed pediatric patients with self-limited epilepsy with centrotemporal spikes – Alexandre N. Datta (Switzerland)
• Neuropsychological profile of late onset epilepsy of unknown aetiology: insights into cognitive functioning – Alessia Casarini (Italy)
• Neurocognitive outcomes of in utero exposure to antiseizure medication: an Australian cohort study – Eliza Honybun (Australia)
• Patterns of long-term cognitive decline following epilepsy surgery – Isha Puntambekar (United Kingdom)

Paediatric Epileptology 1

Co-chairs: Sam Gwer (Kenya) and Kette Valente (Brazil)

• Management of neonatal seizures, insights from EpiCARE Study Survey – Laia Nou-Fontanet (Spain)
• Zorevunersen demonstrates potential as a disease modifying therapy in patients with Dravet syndrome through durable seizure reduction and improvements in cognition, behavior, and functioning with up to 36 months of maintenance dosing in open-label extension studies – Andreas Brunklaus (United Kingdom)
• High-Frequency Oscillations In Scalp EEG as Biomarkers of Epileptogenesis Following Neonatal Seizures – Panagiota Karatza (Switzerland)
• Pediatric Epilepsy Surgery: Global Trends in Invasive Explorations – Georgia Ramantani (Switzerland)
• Early electro-clinical features as predictors of Global Disease Outcome in patients with Epilepsy onset within the first year of life – Marta Conti (Italy)
• Epileptic and developmental encephalopathy secondary to inversion-duplication of chromosome 15q: description of epilepsy characteristics and best therapeutic options – Cristina Benítez Provedo (Spain)

Paediatric Epileptology 2

Co-chairs: Jithangi Wanigasinghe (Sri Lanka) and Kees Braun (Netherlands)

• Decreased interictal heart rate variability in children and adolescents aged 6-14 years with epilepsy – Jinping Zhou (Germany)
• Ictal emotional features in pediatric and young adult patients with frontal lobe epilepsy: insights from developing brain – Ming-Chen Tsai (USA)
• Cortical oscillatory activity evoked by chirp: a biomarker of gabaergic interneuron dysfunction in Dravet syndrome – Nadia Irazabal (Spain)
• Evolution of ictal epileptogenic foci over time in children with tuberous sclerosis complex – Kees Braun (Netherlands)
• Better Breathing, Better Seizure Control: Sleep Apnea in Children with Drug Resistant Epilepsy – Nuria Lamagrande (Spain)
• Potential role for microRNAs as biomarkers in epilepsy: a prospective paediatric study – Licia Salimbene (Italy)

Psychiatry

Co-chairs: W. Curt LaFrance (USA) and Marco Mula (United Kingdom)

• A data-driven MRI study of neurobehavioral comorbidities in temporal lobe epilepsy – Fatemeh Fadaie (Canada)
• Neuropsychological, neurophysiological and imaging features of Juvenile Myoclonic Epilepsy: Insights into personality disorders – Lucas Rainer (Austria)
• Revisiting Hughlings Jackson’s dreamy state: dissociative symptoms in temporal lobe epilepsy – Fiore D'Aprano (Australia)
• Towards culturally competent epilepsy care: An international comparison of self-stigma, psychological factors, and societal attitudes – Izumi Kuramochi (Japan)
• Relationship between Stigma, Loneliness, Depression and Social Support and Suicidal Behavior in Patients with Epilepsy – Kubra Yeni (Turkey)
• The efficacy of eye movement desensitisation and reprocessing therapy in reducing epilepsy-related anxiety – Kamala Broekman-Labinac (Netherlands)

Social Issues

Co-chairs: Alison Kukla (USA) and Melody Asukile (Zambia)

• Epilepsy and Stigma: A multicenter study from Turkey – Aylin Reyhani (Turkey)
• EpilepsyPOWER: a three-year project to favor workplace inclusion of people with epilepsy – Flavia Narducci (Italy)
• Fill-in the dot: Advancing collaboration European patient communities for rare and complex epilepsies in the era of genetics ethiologies – Isabella Brambilla (Italy)
• D’Unseen - Navigating what really matters: Insights from ethnographic research on Dravet Syndrome – Rima Nabbout (France)
• Unpredictable Seizures and Disruptive Behavior in Developmental and Epileptic Encephalopathies: Interim Results of a Caregiver Survey - Andrea L. Wilkinson (USA)
• What Do We Know About the Challenges Faced by Women Professionals in the Epilepsy Field: A 2025 report – Ana Suller Marti (Canada)

Session title: Fred Andermann Lecture in Clinical Epileptology
Co-chairs: J Helen Cross (United Kingdom) and Samuel Wiebe (Canada)

• The curse of propagation: can we know where epileptic activity comes from? – Jean Gotman (Canada)

Full Day Surgical Symposium: The technical landscape of epilepsy surgery
Co-chairs: Arthur Cukiert (Brazil) and Dario Englot (USA)

• How I do it: LITT – Robert Gross (USA)
• How I do it: SEEG-guided RF lesions – Laura Tassi (Italy)
• How I use intraoperative imaging – Karl Rössler (Austria)
• Is there a role for FUS in epilepsy? – Chima Oluigbo (USA)
• Comparing the techniques for hemispherotomy – Christian Dorfer (Austria)
• Radiofrequency procedures in epilepsy surgery – Sarat Chandra (India)
• Surgical commission activities 2021–2025 – Dario Englot (USA)

Case Scenarios:

Part I Moderators: Arthur Cukiert (Brazil) and Guy McKhann (USA)

Part II Moderators: Arthur Cukiert (Brazil) and Kensuke Kawai (Japan)

How we approach people with refractory epilepsy and:

Perisylvian Polymicrogyria

• Case I – Didier Scavarda (France)
• Case II – Guoming Luan (China)

Periventricular nodular heterotopia

• Case I – Jim Baumgartner (USA)
• Case II – Jorge Gonzalez-Martinez (USA)

Mesial temporal sclerosis

• Case I – Mario Alonso-Vanegas (Mexico)
• Case II – Nitin Tandon (USA)

Focal cortical dysplasia IIb

• Case I – Michele Rizzi (Italy)
• Case II – Faisal Al-Otaibi (Saudi Arabia)

LEATs

• Case I – Bertil Rydenhag (Sweden)
• Case II – Sarah Ferrand-Sorbets (France)

Tuberous sclerosis

• Case I – Howard Weiner (USA)
• Case II – George Dorfmuller (France)

Hypothalamic Hamartoma

• Case I – Daniel J. Curry (USA)
• Case II – Hiroshi Shirozu (Japan)

Insula epilepsy

• Case I – Alexander Weil (Canada)
• Case II – Aria Falla (USA)

Dominant TLE with normal MRI

• Case I – Takamichi Yamamoto (Japan)
• Case II – Guy McKhann (USA)

Session title: DEE vs progressive deterioration – have we made progress?
Chair: Elena Gardella (Denmark)

• Introductory talk - patient/family experience – Christophe Lucas (parent) (France)

DEE with SWAS

• Definitions revisited - The range of presentation – Roberto Horacio Caraballo (Argentina)
• Management options & outcomes – have we moved forward? – Bernardo Dalla Bernardina (Italy)

PME

• The Progressive Myoclonus Epilepsies- what’s in a definition? – Samuel Berkovic (Australia)
• Gene therapy for the treatment of PMEs: from preclinical studies to clinical trials – Jose María Serratosa (Spain)

Rasmussens

• 50 years of Rasmussens – where are we now? – J Helen Cross (United Kingdom)
• New horizons in the research and treatment of Rasmussen's Syndrome – Coral Stredny (USA)

Session Title: The neurobiology of epilepsy comorbidities – opportunities for disease modifying therapies?

Co-chairs: David Henshall (Ireland) and Eleonora Aronica (Netherlands)

• Potential cellular and network mechanisms underlying epilepsy and associated cognitive deficits and depression – Christophe Bernard (France)
• Memory dysfunction in epilepsy: from mechanisms to neuromodulation – Jennifer Gelinas (USA)
• Sex Differences in Cognitive, Behavioural, and Neuromotor Comorbidities in Acquired Epilepsy – Pablo Casillas-Espinosa (Australia)
• Insights into the genetics of spreading depression and its impact on cognition and seizures – Jeffrey Noebels (USA)

Title: Individualized Nursing Care for People with Epilepsy: Promoting Education and Self-Management

Co-chairs: Ludivine Rohrer (France) and Tolu Olaniyan (United Kingdom)

Section 1: Promoting Epilepsy Self-Management – Regional Variations

• Living with Epilepsy – Torie Robinson (United Kingdom)
• Assessing Self-management Needs – Wendy R. Trueblood Miller (USA)
• Tackling Health Disparities with Self-management Education – Karen McLeod (United Kingdom) and Faith Sila (Kenya)
• The “Invisible Patients” in Epilepsy: Needs of Caregivers and Partners – Adel Bounif (Luxembourg) and Marion Danse (France)
• Engaging People with Epilepsy and Intellectual/Cognitive Comorbidities – Ariane Bernier (Switzerland)

Section 2: About Safety Management: Are we doing enough to keep people safe?

• Adherence with Care: Does it start with engagement? – Katherinne Moreno Duran (Chile)
• Managing Risks for Early Death and SUDEP – Alwina Koch (Germany)
• Safety and Children: Preventing Risks in Childhood Epilepsy – Zahide İyi Altınışık (Turkey)
• Epilepsy and Physical Exercise: What Nurses Need to Know – Glauber Lopim (Brazil)

Co-chairs: Carla Bentes (Portugal), Margitta Seeck (Switzerland), and Ana Rita Peralta (Portugal)

• Introduction – Carla Bentes (Portugal) and Margitta Seeck (Switzerland) 
• Minimum standards for inpatient long-term video-EEG – TBC
• How to test a patient during seizures – Sándor Beniczky (Denmark)
• Cortical mapping – Valeria Mariani (Italy)
• Safety issues in the epilepsy monitoring unit – Philippe Ryvlin (France)

Pre-registration is required to attend this research workshop. Please register by completing this form.

Please direct any questions to iec@epilepsycongress.org

Session title: Preclinical common data elements for epilepsy research: use, benefits, solutions, future in epilepsy research and discovery

Co-chairs: Aristea Galanopoulou (USA) and Heidrun Potschka (Germany)

Clinical CDEs

• Genetics data standards and data sharing: success through collaboration – Sam Berkovic (Australia)

Preclinical CDEs for epilepsy (TASK3)

• Overview (TASK3, EpiBioS4Rx) – Aristea Galanopoulou (USA)
• Examples (rigor) – Heidrun Potschka (Germany)

Other preclinical CDE resources

• NINDS PTE CDEs / NT-PRECEDS - PRECISE TBI & FITBIR (TBI) – Severn Churn (USA)
• CURE Epilepsy CDEs – SUDEP – Laura Lubbers (USA)
• Implementation of CDEs in research collaborations – Anna Maria Katsarou (USA)
• Epilepsy Science Platform – Joost Wagenaar (USA)

Funders

• NINDS CDEs & Data sharing – Severn Churn (USA)
• European initiatives – data sharing – Ana Teresa Maia Mota (Belgium)

Discussion – all speakers, Piero Perucca (Australia), and Daniel Friedman (USA)

Session Title: Data Blitz: Neurobiology on the Spot

Co-chairs: Solomon Nico Moshé (USA) and Elif Tugce Erdeve (Turkey)

• In-vivoevidence for increased tau deposition in temporal lobe epilepsy – Raul R. Cruces (Canada)
• Gut-based interventions improve neurological consequences of acute brain injury in mice – Rossella Di Sapia (Italy)
• Epicenters of postoperative atrophies are associated with seizure outcomes in temporal lobe epilepsy – Zhoukang Wu (China)
• Neural correlate of the sense of agency in voluntary movement in patients with non-epileptic motor functional paroxysmal events – Mayra Jazmin Morales-Armenta (Mexico)
• Regional Somatic Mosaicism in Focal Pediatric Epilepsy – Westley Philips (United States)
• Tau Deposition: A Potential Marker of Sleep and Memory Impairment in Focal Drug-Resistant Epilepsy – Thaera Arafat (Canada)
• Increased activity of inhibitory interneurons at ictal onset in human temporal lobe seizures – Alejandro Nasimbera (Argentina)
• Potential role for microRNAs as biomarkers in epilepsy: a prospective paediatric study – Licia Salimbene (Italy)
• Electrical, metabolic, and genetic cascades in focal epilepsy – Aaron E.L. Warren (United States)

Session title: ILAE Wikipedia Workshop and Publishing

Co-chairs: Michael Sperling (USA) and Nandan Yardi (India)

• Introduction – Michael Sperling (USA) and Nandan Yardi (India)

How to publish and review in Epilepsia and Epilepsia Open:

• Publishing – Fernando Cendes (Brazil)
• Reviewing – Merab Kokaia (Sweden)
• The importance of Wikipedia as repository for AI – Samuel Wiebe (Canada)
• Our experience with improving articles on Wikipedia and Expert communities – Nandan Yardi (India)
• Let's learn to edit on Wikipedia – Amin Azzam (USA)
• Contributing to Wikipedia – Jonah Fox (USA)
• How you can generate stub articles – John Byrne (United Kingdom)

Brainstorming Sessions

Brain Storming Session 1

Session Title: The epileptic heart

• Terence O'Brien (Australia) 

Brainstorming Session 2

Session Title: Neuropsychiatric profiles of epilepsy patients

• Katia Lin (Brazil)

Brainstorming Session 3

Session Title: Astrocytes and epilepsy

• Peter Bedner (Germany)

Career Development Sessions

Career Development Session 1

Session Title: How is Centre for Global Epilepsy going to address the global challenges in epilepsy care?

• Arjune Sen (United Kingdom)

Career Development Session 2

Session Title: How to become an editor? Internship of Epilepsia Open and Epileptic Disorders

• Aristea Galanopoulou (USA)
• Sándor Beniczky (Denmark) 

Career Development Session 3

Session Title: Changing epilepsy care through entrepreneurship

• Mark Cook (Australia)

ILAE Neurotechnology Session 1

Session Title: Epilepsy past and future

• Some historical stories in neurotechnology – Jean Gotman (Canada)
• Novel modes of ASM delivery - the seizure patch – Stan Skafidas (Australia)

ILAE Neurotechnology Session 2

Session Title: Advanced EEG applications

• EEG-fMRI Current state and future directions – Serge Vulliemoz (Switzerland)
• Seizure Monitoring with Ultra-long term Subscalp EEG – Pedro Viana (United Kingdom)

ILAE Neurotechnology Session 3

Session Title: Emerging Technologies - Shark Tank Winners

• Neumirna Therapeutics – Janine Erler (Denmark)
• Neuronostics – Emanuela De Falco (United Kingdom)

ILAE Neurotechnology Session 4

Session Title: EEG Debate: Is the routine EEG losing relevance?

• No – Sushma Goyal (GSTT)
• Yes – Lisbeth Hernandez Ronquillo (Canada)

Session Title : Leveraging Nursing Expertise and Research to Advance Innovative Approaches in Epilepsy Care: Session 1

• Meeting the Care Needs of Families and Patients with a Developmental and Epileptic Encephalopathies Clinical Nurse Consultant – Brialie K Forster (Australia)
• Assessing Diagnostic Accuracy for Seizures and Seizure Mimics in an Unscheduled Care Setting – Claire Behan (Ireland)
• Construction and Application of Medical Game-based Nursing Care Program for Medical Fear in School-age Children with Epilepsy – Xinjuli, Cuijuanxin, Hewang, Shuangwang, Chenyangwu, Xiunanli, Yingyuhu (China)
• Advancements in Nursing Practice and Patient Support – Aubrey Chawira (United Kingdom)

Session Title : Leveraging Nursing Expertise and Research to Advance Innovative Approaches in Epilepsy Care: Session 2

• ‘Less is More’; Addressing Polypharmacy to Enhance Epilepsy Care – Anne Gough (Ireland)
• The Relationship Between Stigma and Psychological Distress Among Chinese Youth with Epilepsy: The Mediating Role of Physical Activity – Shuagzi Li (China)
• The CPFT Epilepsy Emergency Clinic – Aubrey Chawira (United Kingdom)

Session Title : Leveraging Nursing Expertise and Research to Advance Innovative Approaches in Epilepsy Care: Session 3

• Building Sustainable Epilepsy Care in High-Turnover Settings: A Protocol Driven Nurse-Led Model – Debbie Mak Yee Tung (Hong Kong)
• Understanding and Improving Knowledge Gaps on Women’s Issues and Epilepsy: A Global Perspective for Healthcare Professionals – Lucretia Long (USA), Carmella Redhead (Canada), and Michelle Phillip-Duncan (Trinidad)
• Improving Access and Involvement in Reproductive Health Planning – Janine Winterbottom (United Kingdom)
• Multidisciplinary Epilepsy/Pregnancy Consultations – Nadine VAN DYK (France)

Session Title : Leveraging Nursing Expertise and Research to Advance Innovative Approaches in Epilepsy Care: Session 4

• Cultural Barriers and Coping Strategies in Epilepsy Care in Resource-Limited Areas: A Qualitative Study – Lin Lan, Gao Ruixue, Yin Li, and Liu Xinmin (China)
• 10 Years of Educational and Recreation Camps for Children with Epilepsy in Croatia – N Bedekovic, K Kuznik , M Malenica , M Kukuruzovic , I Separovic , and T Trbojevic (Croatia)
• Exploring the Experience of Stigma Among Children and Adolescents with Epilepsy in China: A Qualitative Study – Zhaojing (China)

ILAE Pharmacy Session 1

Session Title: Basics of Therapeutic Drug Monitoring

- Cecile Johannessen Landmark (Norway)

ILAE Pharmacy Session 2

Session Title: Patient Education and the Pharmacist

- Janet Mifsud (Malta)

ILAE Pharmacy Session 3

Session Title: Pharmacist Involvement in Caring for People with Epilepsy

- Timothy Welty (USA)